We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

KMK Kromek Group Plc

-0.20 (-2.72%)
27 Feb 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Kromek Group Plc LSE:KMK London Ordinary Share GB00BD7V5D43 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.20 -2.72% 7.15 6.80 7.50 7.35 7.15 7.35 490,074 12:00:16
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Miscellaneous Metal Ores,nec 17.31M -6.1M -0.0102 -7.01 42.92M
Kromek Group Plc is listed in the Miscellaneous Metal Ores sector of the London Stock Exchange with ticker KMK. The last closing price for Kromek was 7.35p. Over the last year, Kromek shares have traded in a share price range of 3.15p to 8.55p.

Kromek currently has 600,247,000 shares in issue. The market capitalisation of Kromek is £42.92 million. Kromek has a price to earnings ratio (PE ratio) of -7.01.

Kromek Share Discussion Threads

Showing 4801 to 4822 of 7250 messages
Chat Pages: Latest  194  193  192  191  190  189  188  187  186  185  184  183  Older
If the CEO says the results are positive in interviews repeatedly - that suggests that he is in possession of the results.

If the CEO says the results are in the coming days - that suggests they are imminent.

Where are they?

The detector is a pretty big part of Kromeks offering to shareholders. He shouldn’t be playing games with the results. I expected them today and I’m getting very frustrated they are being withheld.

Its pretty condescending 33mick to suggest I don’t understand engineering well enough to have a view on the handling of the results

AQC888 did you get to read the last Paul Hill Equity Development article?
It got missed by some as it came out on the same day the last ST Investor Chronicle update was released.
From memory it did say live trials/testing of prototypes were planned and thought to take a 'few' months which is reasonable ito my mind.
It was an extensive article and showed the other pro-types, vehicle mounted and such, the one in the airport wasn't shown as its an all new one ment for floor space in high footfall areas.
I'm not sure where you read/heard about trails from the beginning of the year...they only announced the UK innovate contract/project in Jan this year.
I don't share your feelings of being mislead by management at all.
Almost all the design engineers/ companies/manufacturing plants have been in someway restricted by remote working from home or delays with part supply (PCB boards/Chips mentioned this morning by Kromek)
I've been very impressed that they got those first units up and running.
But that's because my job is design of engineering products and systems and components, they've done very well in my book.

Ok AQC888, in this world nothing is guaranteed we all know that.
Kromek are the only Tech company in the UK and arguably the US that have had such backing to develop thier Bio dection units, they were originally for multi patho virus / bacterial / anthrax detection, they've in parallel in record time developed a pure Covid unit being tested/trialed and now we're told today as I understand -
Technically assessed for accuracy and performance by the if you like a 3rd party accreditation. There is no 'airborne viral' standards actually to meet so they are in communication with gov bodies to gain accredition etc..we know its as accurate as PCR.

With no doubt news to follow.

The other core parts of the business are back on track and firing on all cylinders, that was the facts we heard from Kromek this morning.

There's none if the skulldungery you's a woefully unrealistic expectation of what can be humanly achieved by any tech company designing and testing a new product that seems to frustrate you. You're probably not alone as not everyone has a technical mind or product development knowledge.

Things are all starting to line up here.

Just coming thro what for most companies has been the worse period imaginable with Covids shutdowns Kromek's results today are more than impressive to many.

What else exactly was inaccurate/misleading?
33mick, winning government funding for a product does not equate to, or guarantee, a successful product being developed.
QP - where are you viewing the presentation?

I think the more who see it the better.

It takes away from the trials and focusses on the whole company, with the bio-detection as an exciting bonus.

11:32's very frustrating reading your inaccurate and misleading posts.
You have a very poor grasp of information you read and hear and for some reason decide to believe another version of imagined events.

Technology and Science and Product first fully US/UK gov funded..seems completely missed by you!!

Nothing you say I find correct or factual...sorry your the Muppet here.

Amazing results buying more on this fall which is unwarranted
Very predictable results. A lot of exciting news in the pipeline, as always... Past promises forgotten - no results from the trial. (Results to the trial were to come in the coming days, last month). Recovery of the £13m AROC exception (from 2020) is now considered doubtful and it has been revealed it relates to doubtful/bad debts (rather than written off stock held by Kromek - as Simon Thompson stated).

Given Simon Thompson seems to have been mislead not even a repeat tip can be expected. I’m doubtful that the Chinese government don’t consider workers for a hospital imaging system as essential workers and refuse them entry.

Very frustrated by the lack of details regarding the trial. Supposedly they have been in trials for over 6months. (Although as we learned from the Teeside Mayor this was not the case, they only started 1month ago).

I can understand the trials are ongoing and they are refining the system for different environments. But no details at all regarding the trials other than vague references to them being as good as pcr tests??? If that’s the case why aren’t they releasing specific details on this information to show how wonderful it is?? We’re just left to ‘believe’; what the CEO tells us. Kromek is beginning to feel like being a member of a cult. Nobody is allowed to see any evidence of the game changer covid machine. We just have to listen and ‘believe’; in it. Alot of smoke and mirrors. Just enough information given about the biological pathogen detector to keep people holding on, but not any actual evidence of its effectiveness from the trials. Very frustrating.

QP - Yep, Paul Farquhar CFO was present and gave a good run through of figures at the start. He also answered questions that were best answered by him. I took a bunch of "notes" which I hope to have a good look at soon.


Lots of red-herrings with Kromek. The $159m 4/4/14 contract..... The ventilator contract....

They obviously knew some time back that the ventilator project was cratering. I just wonder to myself if it would have been good corporate etiquette to mention how it was progressing.

Question please. Haven't had the chance to view the presentation but will do in due course.

Was the Finance Director present and did (as customary in annual results presentations) the Finance Director give a thorough run-through of figures?



QuePassa - I think you're chasing a red herring here. Ventilators were a potential that never came about. That's all. If you wanna beat KMK with a stick, I would say there's other ways to do it. Ventilators aren't a part of KMK's core business. Agreed, they probably never should have mentioned anything in an RNS unless it was actually 100% going to result in sales, as this leads to 'boy who cried wolf' affect.

From the presentation, I've moved so far on from that RNS. It's history. Not KMK's finest moment. But a small blip that in no way has affected KMK's core business.

The presentation showed a quality company with some really exciting possibilities. Let's see where the share price is, this time next year. I am watching and would now add more.

I bet the Navy s Covid problems were related to this latest MOD contract.

Today's Proactive Investors comments.

"Kromek targets record annual revenues after securing new contracts"

"In Kromek’s new target area of biological-threat detection, the detection specialist has been awarded a £349,000 contract with the UK Ministry of Defence to develop its technology to meet defence and security"

Thank you Doug for asking the question and eliciting an answer on the Ventilators.


So despite the fanfare of their announcement, now we know according to your response that ZERO VENTILATORS were made during a time of grave national crisis.

And a curious response that it was an issue with the UK government , not theirs.

Must say , I don't really comprehend that. At that time, I thought the UK government was desperate for ventilators.

But putting that conundrum to one side, in the same 15/4/20 RNS announcing the VENTILATOR project, Kromek said that the ventilators were to be sold in the UK and GLOBALLY.

" Following the signing of a license agreement, which is expected shortly, Kromek intends to sell the ventilators in the UK and globally."

Well, what about their GLOBAL sales of ventilators? Surely that can't be laid at the door of the UK government. What happened there?


Today..BBC news-

I was amazed there was no talk of it as she sailed out of Portsmouth only to return a few weeks later..and leave at a latter date.

All those matlos were double jabbed, double PCR tested before boarding and it appears nothing can detect it well enough.

'An outbreak of Covid-19 has been confirmed on the Royal Navy's flagship, HMS Queen Elizabeth.

The BBC has been told there have been around 100 cases on the aircraft carrier, which is part way through a world tour.

Several other warships in the fleet accompanying it are also affected.

Defence Secretary Ben Wallace said all crew on the deployment had received two doses of a Covid-19 vaccine and the outbreak was being managed.

HMS Queen Elizabeth is about a quarter of the way through a 28-week deployment leading the Carrier Strike Group (CSG).

It has now entered the Indian Ocean, and the Royal Navy says it is due to continue on its voyage to Japan later this year.'

Very good write up Doug, I'm glad I tuned in, seems all very positive to me in all areas, the future potential bio detection/monitoring units sales are as you state not factored in to any projections. So to my eyes a very exciting story to follow.

NHS based 3rd party accuracy and sensitivity tests being carried out If I heard correctly?

Manufacturing/Production lines being sounded out.

And even the Chinese/Asian customer still could come good. All products in store awaiting onsite installation when techies can travel I believe.

[1] I asked about any fundraising, answer was 'no' in the short / medium term.
Maybe for a specific acquisition at some point, but a firm 'no'.

[2] The 13 million Chinese product system is still there and will be delivered as a system as soon as people movement opens up.

[3] The ventilators could have been made, but 0 were made. UK government, not KMK issue. Main point here though is that was just making something under license. The bio-detection excitement is totally different, this is creating intellectual property rights that is funded by 3 different agencies. So any skepticism felt due to the ventilators, shouldn't be carried over to the bio-detection.

[4] On track to deliver significant revenue growth for full year 2022. 15 million revenue for '22, which is 50% growth (am I correct here?). This already has 76% visibility and the remainder should be easily achieved through pipeline. This does not include any of the bio-detection either (I think).

[5] The medical imaging side sounded exciting too. 100 million possibility opening up. KMK and 1 competitor only, where KMK has the edge. Could be exciting.

I feel after watching that more confident in this company than I ever have been. Their core businesses are also on the move. It's not just about COVID and pathogen detection. There are multiple milestones that can be achieved in 2022 to allow commercial development of the bio-threat detection systems.

A lot more too. Watched and wrote this whilst teaching the wife to drive!

Hope helps, cheers.


At what point do you consider a strategic review of your ip / assets to determine if their true value would be achieved if part of a larger well financed company.

Please ask a simple question.

How many VENTILATORS sold .

Thank you.

Am on the presentation, any questions post them here.
I can add them to the presentation chat.

anyone has the link to webinar presentation at 9.30
Thanks Doug, had probs replying to you.
Fat finger this end .hahaa
Or the Ipa I was trialing.

Chat Pages: Latest  194  193  192  191  190  189  188  187  186  185  184  183  Older

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 |